Author | Rutika Mehta, MD, MPH | OncLive

Author | Rutika Mehta, MD, MPH

Articles

Dr. Mehta on TAS-102/Ramucirumab Combo Trial in Gastric/GEJ Cancer

October 02, 2019

Video

Rutika Mehta, MD, MPH, discusses a phase II trial that will combine ramucirumab with TAS-102 in patients with advanced gastric and gastroesophageal junction cancer.

Dr. Mehta on Recent Progress Made in Advanced Gastric Cancer

September 24, 2019

Video

Rutika Mehta, MD, MPH, gastrointestinal medical oncologist, Moffitt Cancer Center, discusses recent progress that has been made in advanced gastric cancer.

Dr. Mehta on Rationale for a Phase II Trial of TAS-102/Ramucirumab in Gastric/GEJ Cancer

June 19, 2019

Video

Rutika Mehta, MD, MPH, gastrointestinal medical oncologist, Moffitt Cancer Center, discusses the rationale and design of a phase II study of TAS-102 (trifluridine/tipiracil; Lonsurf) in combination with ramucirumab (Cyramza) in patients with advanced, refractory gastric or gastroesophageal junction (GEJ) adenocarcinoma (NCT03686488).

Dr. Mehta on Immunotherapy in Gastric/GEJ Cancer

March 22, 2019

Video

Rutika Mehta, MD, MPH, gastrointestinal medical oncologist at Moffitt Cancer Center, discusses the use of immunotherapy in patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma.

x